A protein tied to ALS and dementia may have a much bigger role in disease than scientists realized. Researchers found that ...
Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.
Researchers at the University of Alabama at Birmingham are working to better understand ALS and find new ways to slow or stop the disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results